Apimeds Pharmaceuticals US, Inc (APUS) has 10 identified peers for comparison in the Healthcare sector. Peers include ANTX, IGC, MIRA, MLSS, MYO, NXTC and others.
APUS has a market capitalization of $2.36M, compared to an average peer market cap of $42.59M. APUS is notably smaller than its average peer.
